Source: National Institute for Health Research – Service, Delivery and Organisation programme
Area: News
The first year results from an NIHR Health Technology Assessment (HTA) programme funded trial, IVAN (inhibit VEGF in age related choroidal neovasc…
Day: May 10, 2012
An Evidence Integration Triangle for Aligning Science with Policy and Practice
By: purcellp
Octanoate and Nonanoate Oxidation Increases 50-80% Over the First Two Days of Life in Piglet Triceps Brachii and Gracilis Muscle Strips
By: Thomas D. Crenshaw
New Advances In Treating Inherited Retinal Diseases
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in …
Topical Aganirsen Found To Be Active In Retinal Disease
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced that positive data from a study of aganirsen (GS-101, eye drops) in a nonhuman primate model of choroidal neovascularization has been p…